Quite interesting opinion on HSCT in MS can be found here
Is it ethical not to inform patients about possibility of HSCT in MS? I think if the doctors know the data of the trials and publications they will talk with the patients about HSCT. I do believe that not ethical action of not informing patients about that possibility does come from doctors (neurologists) not knowing and understanding how powerful HSCT can be in this disease. It is amazing to see how HSCT goes into the spotlight in recent years.